Cormorant Asset Management’s Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022 OTLKW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-270,698	Closed	-$32K	–	86
2021 Q4	$32K	Hold	270,698	–	–	﹤0.01%	78
2021 Q3	$54K	Sell	270,698 -145,968	-35%	-$29.1K	﹤0.01%	88
2021 Q2	$130K	Hold	416,666	–	–	﹤0.01%	100
2021 Q1	$421K	Buy	+416,666	New	+$421K	0.01%	113
2020 Q4	–	Sell	-416,666	Closed	-$54K	–	110
2020 Q3	$54K	Hold	416,666	–	–	﹤0.01%	87
2020 Q2	$117K	Hold	416,666	–	–	﹤0.01%	77
2020 Q1	$65K	Hold	416,666	–	–	﹤0.01%	68
2019 Q4	$27K	Hold	416,666	–	–	﹤0.01%	61
2019 Q3	$50K	Hold	416,666	–	–	﹤0.01%	67
2019 Q2	$46K	Hold	416,666	–	–	﹤0.01%	65
2019 Q1	$150K	Hold	416,666	–	–	0.01%	62
2018 Q4	$64K	Buy	+416,666	New	+$64K	0.01%	64